X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS WOCKHARDT LTD. DR. DATSONS LABS/
WOCKHARDT LTD.
 
P/E (TTM) x -10.9 -11.3 - View Chart
P/BV x 0.2 2.2 7.2% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 DR. DATSONS LABS   WOCKHARDT LTD.
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
WOCKHARDT LTD.
Mar-17
DR. DATSONS LABS/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1261,129 11.1%   
Low Rs31627 4.9%   
Sales per share (Unadj.) Rs133.0363.1 36.6%  
Earnings per share (Unadj.) Rs0.2-20.4 -0.7%  
Cash flow per share (Unadj.) Rs6.6-7.0 -94.7%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs128.8301.8 42.7%  
Shares outstanding (eoy) m31.66110.55 28.6%   
Bonus/Rights/Conversions FCCBIS-  
Price / Sales ratio x0.62.4 24.3%   
Avg P/E ratio x516.1-42.9 -1,201.9%  
P/CF ratio (eoy) x11.8-125.9 -9.4%  
Price / Book Value ratio x0.62.9 20.9%  
Dividend payout %0-48.9 0.0%   
Avg Mkt Cap Rs m2,47797,063 2.6%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m569,665 0.6%   
Avg. sales/employee Rs ThNM5,931.8-  
Avg. wages/employee Rs ThNM1,428.1-  
Avg. net profit/employee Rs ThNM-334.0-  
INCOME DATA
Net Sales Rs m4,21140,146 10.5%  
Other income Rs m791,143 6.9%   
Total revenues Rs m4,28941,289 10.4%   
Gross profit Rs m569128 444.2%  
Depreciation Rs m2041,489 13.7%   
Interest Rs m4302,253 19.1%   
Profit before tax Rs m13-2,472 -0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-211 -2.9%   
Profit after tax Rs m5-2,260 -0.2%  
Gross profit margin %13.50.3 4,235.5%  
Effective tax rate %48.08.5 562.3%   
Net profit margin %0.1-5.6 -2.0%  
BALANCE SHEET DATA
Current assets Rs m6,85246,160 14.8%   
Current liabilities Rs m6,71119,258 34.8%   
Net working cap to sales %3.367.0 5.0%  
Current ratio x1.02.4 42.6%  
Inventory Days Days161101 159.7%  
Debtors Days Days31894 338.6%  
Net fixed assets Rs m3,67340,165 9.1%   
Share capital Rs m317553 57.3%   
"Free" reserves Rs m3,76132,814 11.5%   
Net worth Rs m4,07833,367 12.2%   
Long term debt Rs m1,67131,903 5.2%   
Total assets Rs m12,63389,687 14.1%  
Interest coverage x1.0-0.1 -1,060.0%   
Debt to equity ratio x0.41.0 42.9%  
Sales to assets ratio x0.30.4 74.5%   
Return on assets %3.40 -40,108.4%  
Return on equity %0.1-6.8 -1.7%  
Return on capital %7.7-0.3 -2,289.1%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9649,121 10.6%   
Fx outflow Rs m6072,133 28.5%   
Net fx Rs m3576,988 5.1%   
CASH FLOW
From Operations Rs m1,345-2,695 -49.9%  
From Investments Rs m-2,256-6,863 32.9%  
From Financial Activity Rs m-1,20012,545 -9.6%  
Net Cashflow Rs m-2,1113,010 -70.1%  

Share Holding

Indian Promoters % 4.5 74.5 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.3 -  
FIIs % 1.4 7.7 17.5%  
ADR/GDR % 0.0 0.1 -  
Free float % 94.1 15.4 611.0%  
Shareholders   20,807 67,757 30.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  MERCK LTD  NOVARTIS  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Energy Stocks Lose(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.4% while the Hang Seng is down 0.5%. The Shanghai Composite is trading up by 0.2%.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - TTK HEALTHCARE COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS